Harvest Fund Management Co. Ltd Buys 1,934 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Harvest Fund Management Co. Ltd increased its stake in Axon Enterprise, Inc. (NASDAQ:AXON) by 3,792.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,985 shares of the biotechnology company’s stock after purchasing an additional 1,934 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in Axon Enterprise were worth $793,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Quent Capital LLC increased its holdings in shares of Axon Enterprise by 1,875.0% in the third quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after purchasing an additional 75 shares during the period. Blue Trust Inc. increased its holdings in shares of Axon Enterprise by 987.5% in the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock worth $27,000 after purchasing an additional 79 shares during the period. Planning Capital Management Corp increased its holdings in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares during the period. Friedenthal Financial bought a new position in shares of Axon Enterprise in the third quarter worth $51,000. Finally, Reston Wealth Management LLC bought a new position in shares of Axon Enterprise in the third quarter worth $60,000. Institutional investors own 79.08% of the company’s stock.

Insider Activity

In related news, CEO Patrick W. Smith sold 50,000 shares of the stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $364.02, for a total value of $18,201,000.00. Following the completion of the transaction, the chief executive officer now directly owns 2,980,861 shares of the company’s stock, valued at $1,085,093,021.22. This represents a 1.65 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Julie A. Cullivan sold 900 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the completion of the transaction, the director now directly owns 3,653 shares of the company’s stock, valued at approximately $1,291,445.09. The trade was a 19.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 260,256 shares of company stock valued at $105,984,120. Insiders own 5.70% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several research analyst reports. Robert W. Baird upped their price target on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a report on Monday, November 4th. JMP Securities upped their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Needham & Company LLC upped their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. Northland Securities upped their target price on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research report on Monday, November 11th. Finally, Craig Hallum upped their target price on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $619.00 on Tuesday. The company has a market cap of $47.20 billion, a price-to-earnings ratio of 159.95, a price-to-earnings-growth ratio of 14.02 and a beta of 0.94. The company has a 50-day moving average price of $468.24 and a 200-day moving average price of $370.65. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $224.28 and a 12 month high of $641.20.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.